Sort
261,768 grants matching “gene therapy”
Pharmacogenomics of Arrhythmia Therapy
$2,644,284Dan M Roden · Vanderbilt University · U01 · FY2007 · HL
GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE
$2,644,211Stanford University · U01 · FY2001 · HL
Breast and Other Cancers in the California Teachers Cohort
$2,643,925Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,643,475University Of Washington · U01 · FY2004 · HL
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,643,230Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Mechanisms of sleep and sleep apnea
$2,642,245Clifford B Saper · Beth Israel Deaconess Medical Center · P01 · FY2023 · HL
Integrated Nanosystems for Diagnosis and Therapy
$2,641,898Karen L. Wooley · Washington University · U01 · FY2007 · HL
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
$2,641,224Paul J Kenny · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · DA
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$2,640,821Janet T. Holbrook · Johns Hopkins University · UG1 · FY2021 · EY
Genetic variant-based drug discovery targeting conserved pathways of aging
$2,640,750Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2025 · AG
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,640,406University Of Washington · U01 · FY2001 · HL
In utero CRISPR-mediated gene editing to cure congenital monogenic disorders
$2,640,000William H. Peranteau · Children'S Hosp Of Philadelphia · DP2 · FY2019 · HL
Immunometabolism in Cancer and Inflammation
$2,639,852Daniel W. McVicar · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Pathway Analysis in Tuberculosis
$2,639,702Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
Human autism genetics and activity dependent gene activation
$2,639,516Christopher A Walsh · Boston Children'S Hospital · RC2 · FY2010 · MH
Host Pathogen Variation & TB Pathogenesis
$2,638,886Thomas R Hawn · University Of Washington · U19 · FY2021 · AI
Study Susceptibility and Resistance to ApoE4 in Alzheimer's Disease
$2,637,009Yadong Huang · J. David Gladstone Institutes · RF1 · FY2022 · AG
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,636,978Weill Medical College Of Cornell Univ · U01 · FY2003 · HL
SPORE in Lymphoma
$2,636,949Helen E Heslop · Baylor College Of Medicine · P50 · FY2019 · CA
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,636,665Pamela J Bjorkman · California Institute Of Technology · P01 · FY2014 · AI
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
$2,636,624Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Risk Factors for Onset and Persistence of TMD
$2,635,990William Maixner · Univ Of North Carolina Chapel Hill · U01 · FY2008 · DE
Pharmacogenetics of Nicotine Addiction Treatment
$2,635,621Caryn Lerman · University Of Pennsylvania · U01 · FY2012 · DA
GENERAL CLINICAL RESEARCH CENTER
$2,634,912Baylor College Of Medicine · M01 · FY2000 · RR
Clinical Trials Network, Ohio Valley Node
$2,634,865Eugene C. Somoza · University Of Cincinnati · U10 · FY2007 · DA